Related references
Note: Only part of the references are listed.Humoral immunity to tetanus, diphtheria and polio in adults after treatment for hematological malignancies
Sigrun Einarsdottir et al.
VACCINE (2020)
Diversity of meningococci associated with invasive meningococcal disease in the Republic of Ireland over a 19 year period, 1996-2015
Desiree E. Bennett et al.
PLOS ONE (2020)
The science of vaccine safety: Summary of meeting at Wellcome Trust
Stanley A. Plotkin et al.
VACCINE (2020)
Hepatitis C Virus Vaccine: Challenges and Prospects
Joshua D. Duncan et al.
VACCINES (2020)
Immunization of healthcare personnel in Europe: Time to move forward with a common program
Helena C. Maltezou et al.
VACCINE (2020)
The risk of infections in multiple myeloma before and after the advent of novel agents: a 12-year survey
Annamaria Brioli et al.
ANNALS OF HEMATOLOGY (2019)
Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)
Catherine Cordonnier et al.
LANCET INFECTIOUS DISEASES (2019)
Response to pneumococcal vaccination in multiple myeloma
Loic Renaud et al.
CANCER MEDICINE (2019)
Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis
Alemnew F. Dagnew et al.
LANCET INFECTIOUS DISEASES (2019)
Immunogenicity And Safety Of The 13-Valent Pneumococcal Conjugate Vaccine In Patients With Monoclonal Gammopathy Of Undetermined Significance - Relationship With Selected Immune And Clinical Parameters
Marcin Pasiarski et al.
CLINICAL INTERVENTIONS IN AGING (2019)
Cytomegalovirus Reactivation in a Patient With Extensively Pretreated Multiple Myeloma During Daratumumab Treatment
Kristine A. Frerichs et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2019)
Response to PCV13 vaccination in patients with multiple myeloma versus healthy controls
S. Shahzad Mustafa et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors-Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)
C. T. Rieger et al.
ANNALS OF ONCOLOGY (2018)
Revaccination after Autologous Hematopoietic Stem Cell Transplantation Is Safe and Effective in Patients with Multiple Myeloma Receiving Lenalidomide Maintenance
Meighan Palazzo et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Safety of live-attenuated measles-mumps-rubella and herpes zoster vaccination in multiple myeloma patients on maintenance lenalidomide or bortezomib after autologous hematopoietic cell transplantation
Alisha Pandit et al.
BONE MARROW TRANSPLANTATION (2018)
Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies
Yao-Qing Chen et al.
CELL (2018)
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid or myeloid cells surface antigens [II]: CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4)
L. Drgona et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
Norah A. Terrault et al.
HEPATOLOGY (2018)
Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial
Drew J. Winston et al.
LANCET (2018)
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
A. Danielle Iuliano et al.
LANCET (2018)
NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?
Florian Krammer et al.
MBIO (2018)
Virus reactivations after autologous hematopoietic stem cell transplantation detected by multiplex PCR assay
Natsuko Inazawa et al.
JOURNAL OF MEDICAL VIROLOGY (2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Immunogenicity and persistence of the 13-valent Pneumococcal Conjugate Vaccine (PCV13) in patients with untreated Smoldering Multiple Myeloma (SMM): A pilot study
Mathilde Bahuaud et al.
HELIYON (2017)
Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation-a position paper
L. Sarmati et al.
CLINICAL MICROBIOLOGY AND INFECTION (2017)
Clinical and Serologic Responses After a Two-dose Series of High-dose Influenza Vaccine in Plasma Cell Disorders: A Prospective, Single-arm Trial
Andrew R. Branagan et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2017)
Multiple Myeloma Vaccination Patterns in a Large Health System: A Pilot Study
Andinet Alemu et al.
JOURNAL OF PATIENT-CENTERED RESEARCH AND REVIEWS (2017)
Poor Correlation between Pneumococcal IgG and IgM Titers and Opsonophagocytic Activity in Vaccinated Patients with Multiple Myeloma and Waldenstrom's Macroglobulinemia
Johanna Karlsson et al.
CLINICAL AND VACCINE IMMUNOLOGY (2016)
Vaccination in Multiple Myeloma: Review of Current Literature
Andinet Alemu et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2016)
Herpes Zoster
Kenneth Schmader
CLINICS IN GERIATRIC MEDICINE (2016)
A prospective study on the efficacy of two-dose influenza vaccinations in cancer patients receiving chemotherapy
Yukinari Sanada et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2016)
Antibodies against Hepatitis A and Hepatitis B Virus in Intravenous Immunoglobulin Products
Soyoung Lee et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2016)
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
A. L. Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
New Insights into the Generation of CD4 Memory May Shape Future Vaccine Strategies for Influenza
Priyadharshini Devarajan et al.
FRONTIERS IN IMMUNOLOGY (2016)
Immunization of Health-Care Providers: Necessity and Public Health Policies
Helena C. Maltezou et al.
HEALTHCARE (2016)
Pneumococcal Capsules and Their Types: Past, Present, and Future
K. Aaron Geno et al.
CLINICAL MICROBIOLOGY REVIEWS (2015)
Efficacy of single versus boost vaccination against influenza virus in patients with multiple myeloma
Michael Hahn et al.
HAEMATOLOGICA (2015)
Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update
Jessica P. Hwang et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults
M. J. M. Bonten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Efficacy of single versus boost vaccination against influenza virus in patients with multiple myeloma
Michael Hahn et al.
HAEMATOLOGICA (2015)
Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients
Cecilie Blimark et al.
HAEMATOLOGICA (2015)
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Lorry G. Rubin et al.
CLINICAL INFECTIOUS DISEASES (2014)
Impact of 13-Valent Pneumococcal Conjugate Vaccination in Invasive Pneumococcal Disease Incidence and Mortality
Zitta Barrella Harboe et al.
CLINICAL INFECTIOUS DISEASES (2014)
Long-term risks after splenectomy among 8,149 cancer-free American veterans: a cohort study with up to 27 years follow-up
Sigurdur Y. Kristinsson et al.
HAEMATOLOGICA (2014)
Vaccination of healthcare workers to protect patients at increased risk of acute respiratory disease: summary of a systematic review
Gayle P. Dolan et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2013)
Serologic response to a 23-valent pneumococcal vaccine administered prior to autologous stem cell transplantation in patients with multiple myeloma
Maja Hinge et al.
APMIS (2012)
Risk of Invasive Haemophilus influenzae Type b (Hib) Disease in Adults with Secondary Immunodeficiency in the Post-Hib Vaccine Era
Eli B. Nix et al.
CLINICAL AND VACCINE IMMUNOLOGY (2012)
Lenalidomide-Induced Immunomodulation in Multiple Myeloma: Impact on Vaccines and Antitumor Responses
Kimberly Noonan et al.
CLINICAL CANCER RESEARCH (2012)
Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study
Sigurdur Y. Kristinsson et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Waning Antibody Levels and Avidity: Implications for MMR Vaccine-Induced Protection
Mia Kontio et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales
Nick J. Andrews et al.
VACCINE (2012)
Enhanced Immune Response after a Second Dose of an AS03-Adjuvanted H1N1 Influenza A Vaccine in Patients after Hematopoietic Stem Cell Transplantation
Saskia Gueller et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Comparative Study of Immune Status to Infectious Agents in Elderly Patients with Multiple Myeloma, Waldenstrom's Macroglobulinemia, and Monoclonal Gammopathy of Undetermined Significance
Johanna Karlsson et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host
Hugues de Lavallade et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies
Sanae Sasaki et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Dose-ranging study of a single injection of pneumococcal conjugate vaccine (1 x, 2x, or 4x) in healthy subjects aged 70 years or older
H. Lode et al.
VACCINE (2011)
Quality and Strength of Evidence of the Infectious Diseases Society of America Clinical Practice Guidelines
Abdur Rahman Khan et al.
CLINICAL INFECTIOUS DISEASES (2010)
Utility of Influenza Vaccination for Oncology Patients
Daniel A. Pollyea et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Vaccination of hematopoietic cell transplant recipients
P. Ljungman et al.
BONE MARROW TRANSPLANTATION (2009)
Randomized Study of Early versus Late Immunization with Pneumococcal Conjugate Vaccine after Allogeneic Stem Cell Transplantation
Catherine Cordonnier et al.
CLINICAL INFECTIOUS DISEASES (2009)
Effects of ageing and gender on naturally acquired antibodies to pneumococcal capsular polysaccharides and virulence-associated proteins
Birgit Simell et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Sialobiology of influenza molecular mechanism of host range variation of influenza viruses
Y Suzuki
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2005)
Pertussis in adolescence after unrelated cord blood transplantation
N Suzuki et al.
BONE MARROW TRANSPLANTATION (2003)
Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly
DM Murasko et al.
EXPERIMENTAL GERONTOLOGY (2002)
Cancer patients undergoing chemotherapy show adequate serological response to vaccinations against influenza virus and Streptococcus pneumoniae
T Nordoy et al.
MEDICAL ONCOLOGY (2002)
Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines
T Nordoy et al.
BONE MARROW TRANSPLANTATION (2001)
Antibody responses to pneumococcal and haemophilus vaccinations in patients with B-cell chronic lymphocytic leukaemia
A Hartkamp et al.
VACCINE (2001)
Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma
JD Robertson et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
